Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 42 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

38%

16 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

8 recruiting

Enrollment Performance

Analytics

N/A
13(36.1%)
Phase 3
10(27.8%)
Phase 4
6(16.7%)
Phase 2
4(11.1%)
Phase 1
2(5.6%)
Early Phase 1
1(2.8%)
36Total
N/A(13)
Phase 3(10)
Phase 4(6)
Phase 2(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (42)

Showing 20 of 42 trials
NCT07533305Phase 2Not Yet Recruiting

Efficacy and Safety of QL1706 Combined With Nab-paclitaxel and Cisplatin as 1st Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Role: lead

NCT07289698Recruiting

Handgrip Strength Increases the Pressure in the Portal and Left Gastric Veins in Cirrhotic Patients

Role: collaborator

NCT07354295Recruiting

Integrating Multimodal AI to Predict Treatment Response and Refine Risk Stratification in Esophageal Cancer (Radiogenomics-Esophagus)

Role: collaborator

NCT06765590Not ApplicableRecruiting

Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer

Role: collaborator

NCT06794853Recruiting

Mechanism of TIPS to Improve Sarcopenia

Role: collaborator

NCT07347080Early Phase 1Not Yet Recruiting

A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus

Role: lead

NCT07116096Not ApplicableRecruiting

Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis

Role: collaborator

NCT06298071Phase 1Recruiting

A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.

Role: collaborator

NCT07281846Not ApplicableRecruiting

TIPS With or Without BCAA

Role: collaborator

NCT07269574Not Yet Recruiting

Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance

Role: collaborator

NCT07117266Not ApplicableCompleted

Clinical Application of Automated Interpretation System for Chest X-Ray Images Based on Multimodal Large Models

Role: collaborator

NCT07153744Phase 4Not Yet Recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Role: collaborator

NCT06943690Not ApplicableNot Yet Recruiting

Safety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer Surgery

Role: collaborator

NCT02972372Not ApplicableRecruiting

Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer

Role: lead

NCT05781243Phase 4Completed

Normal Saline Versus Lactated Ringer's Solution for Acute Pancreatitis Resuscitation

Role: collaborator

NCT06728839Not ApplicableNot Yet Recruiting

Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Colonoscopy Cleansing

Role: collaborator

NCT06722300Not ApplicableActive Not Recruiting

Clinical Study on the Impact of Eradication of Oral Porphyromonas Gingivalis on the Prognosis of Early Esophageal Cancer After ESD Surgery

Role: lead

NCT06464614Phase 2Not Yet Recruiting

Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.

Role: lead

NCT06373991Phase 1Not Yet Recruiting

A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus

Role: collaborator

NCT06418945Phase 3Not Yet Recruiting

Clinical Study on the Effect of Removal of Porphyromonas Gingivalis on Prognosis of Esophageal Cancer After Radical Surgery

Role: lead